Journalartikel

Jahr der Veröffentlichung: 2010

Zeitschrift: Arthritis Research and Therapy

Bandnummer: 12

Heftnummer: 4

ISSN: 1478-6354

eISSN: 1478-6362

Open Access Status: Gold

DOI Link: https://doi.org/10.1186/ar3102

Verlag: BioMed Central

Abstract: 
Due to ongoing developments of novel agents in the field of biological pharmacotherapy, there are now more arrows available in clinicians' quivers for the treatment of rheumatic conditions. As a consequence, however, clear treatment strategies have to be defined in order to guarantee a qualitatively high and individually stage-adapted, state-of-the-art regimen for affected patients. This review summarizes recent evidence regarding the rationale of using different biological therapies to treat rheumatoid arthritis, the most common inflammatory joint disorder after activated osteoarthritis, and draws an actual picture of a possible standardized therapeutic algorithm without claiming exclusive appropriateness.

Harvard-Zitierstil: Geyer, M. and Mueller-Ladner, U. (2010) Rationale of using different biological therapies in rheumatoid arthritis, Arthritis Research and Therapy, 12(4), Article 214. https://doi.org/10.1186/ar3102

APA-Zitierstil: Geyer, M., & Mueller-Ladner, U. (2010). Rationale of using different biological therapies in rheumatoid arthritis. Arthritis Research and Therapy. 12(4), Article 214. https://doi.org/10.1186/ar3102